tm logo
ROVIVZEL
Dead/Abandoned
ABANDONED – EXPRESS AFTER PUB

on 13 Mar 2017

Last Applicant/ Owned by

86 Morris Avenue

Summit

NJ

07901

Serial Number

87143093 filed on 18th Aug 2016

Registration Number

N/A

Correspondent Address

CAMILLE M. MILLER

COZEN O'CONNOR

1650 MARKET STREET

SUITE 2800

PHILADELPHIA, PA 19103

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ROVIVZEL

Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Mark Details


Serial Number

No 87143093

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 364433/CELG-

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
13th Mar 2017ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
13th Mar 2017ABANDONMENT - AFTER PUBLICATION
08th Mar 2017TEAS EXPRESS ABANDONMENT RECEIVED
07th Mar 2017PUBLISHED FOR OPPOSITION
07th Mar 2017EXTENSION OF TIME TO OPPOSE RECEIVED
07th Mar 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15th Feb 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02th Feb 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
18th Jan 2017APPROVED FOR PUB - PRINCIPAL REGISTER
06th Jan 2017TEAS/EMAIL CORRESPONDENCE ENTERED